S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
CarMax Slides On Earnings Disappointment, Time To Celebrate?
Costco Isn't Facing Devastating Surges in Theft Like Target and Walmart — and the Reason Is Very Simple
His system isolated NVIDIA - Here's His Next Buy. (Ad)
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
4 Proven Strategies to Help You Find Success in Executive Leadership
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
'Control, Surveillance and Manipulation': How TikTok's Office Surveillance Could Backfire and Cost The Company Billions
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
NYSE:BHC

Bausch Health Companies (BHC) Price Target & Analyst Ratings

$8.22
-0.02 (-0.24%)
(As of 09/29/2023 ET)
Compare
Today's Range
$8.18
▼
$8.34
50-Day Range
$7.73
▼
$9.70
52-Week Range
$5.57
▼
$10.23
Volume
1.78 million shs
Average Volume
3.32 million shs
Market Capitalization
$2.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Bausch Health Companies Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$12.50
52.07% Upside
High Prediction$16.00
Average Prediction$12.50
Low Prediction$9.00
TypeCurrent
9/30/22 to 9/30/23		1 Month Ago
8/31/22 to 8/31/23		3 Months Ago
7/2/22 to 7/2/23		1 Year Ago
9/30/21 to 9/30/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$12.50$8.17$7.83$10.60
Predicted Upside52.07% Upside-0.16% Downside16.43% Upside42.23% Upside
Get Bausch Health Companies Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.


BHC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Bausch Health Companies Stock vs. The Competition

TypeBausch Health CompaniesMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside52.07% Upside867.84% Upside698.21% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy$9.00 ➝ $16.00+106.99%
7/24/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetSector Perform$8.00 ➝ $9.00-6.25%
6/16/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Market Perform
(Data available from 9/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BHC Price Target - Frequently Asked Questions

What is Bausch Health Companies's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Bausch Health Companies stock is Hold based on the current 2 hold ratings and 1 buy rating for BHC. The average twelve-month price prediction for Bausch Health Companies is $12.50 with a high price target of $16.00 and a low price target of $9.00. Learn more on BHC's analyst rating history.

Do Wall Street analysts like Bausch Health Companies more than its competitors?

Analysts like Bausch Health Companies less than other Medical companies. The consensus rating for Bausch Health Companies is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how BHC compares to other companies.

Is Bausch Health Companies being upgraded by Wall Street analysts?

Over the previous 90 days, Bausch Health Companies's stock had 1 upgrade by analysts.

Does Bausch Health Companies's stock price have much upside?

According to analysts, Bausch Health Companies's stock has a predicted upside of 44.26% based on their 12-month price targets.

What analysts cover Bausch Health Companies?

Bausch Health Companies has been rated by Jefferies Financial Group, and Royal Bank of Canada in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:BHC) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -